Prescription pharmaceuticals necessarily require a medical prescription to be dispensed. The definition of prescription drugs varies with different jurisdictions. There has been an increase in the use of prescription medicines since 1960’s. The legal medical prescription will prevent the occurrences of adverse drug reactions due to misuse or abuse of prescription drugs.

Prescription Pharmaceuticals Market Segmentation

The global prescription pharmaceuticals market is segmented by therapeutics and formulation segments. The therapeutics segments of the prescription pharmaceuticals market included in this report are cardiovascular disorders, oncology, inflammatory conditions, infectious diseases, metabolic disorders, respiratory disorders, and other therapeutic segments. Cardiovascular disorders were the largest therapeutic segment in 2015, while infectious diseases are expected to be the fastest-growing therapeutic segment in the forecast period.

The formulation segments of the prescription pharmaceuticals market included in this report are capsules, tablets, inhalants and liquids, parenteral, and topicals. Capsules were the largest formulation segment in 2015, and it is also expected to be the fastest-growing formulation segment in the forecast period.


Table of Content

1. EXECUTIVE SUMMARY

1.1. Research Scope

1.1.1. Market Definition

1.1.2. Market Segmentation

1.1.3. Research Methodology

1.2. Executive Summary

1.2.1. Market Summary

1.2.2. Comparative Analysis

2. MARKET DYNAMICS

2.1. Drivers

2.2. Restraints

2.3. Opportunities

2.4. Trends

3. INDUSTRY ANALYSIS

3.1. Value Chain Analysis

3.2. Regulatory Analysis

3.3. Reimbursement Landscape

3.4. Product Roadmap

4. PRESCRIPTION PHARMACEUTICALS MARKET, BY THERAPEUTIC SEGMENTS

4.1. Introduction

4.2. Cardiovascular Disorders

4.3. Oncology

4.4. Inflammatory Conditions

4.5. Infectious Diseases

4.6. Metabolic Disorders

4.7. Respiratory Disorders

4.8. Other Therapeutic Segments

5. PRESCRIPTION PHARMACEUTICALS MARKET, BY FORMULATIONS

5.1. Introduction

5.2. Capsules

5.3. Tablets

5.4. Inhalants and Liquids

5.5. Parenterals

5.6. Topicals

6. PRESCRIPTION PHARMACEUTICALS MARKET, BY GEOGRAPHY

6.1. Introduction

6.2. North America

6.2.1. U.S.

6.2.2. Canada

6.3. Europe

6.3.1. France

6.3.2. Germany

6.3.3. U.K

6.3.4. Rest of Europe

6.4. Asia-Pacific (APAC)

6.4.1. China

6.4.2. India

6.4.3. Japan

6.4.4. Rest of APAC

6.5.Rest of the World (ROW)

6.5.1. Latin America

6.5.2. Middle East and Africa

7. COMPETITIVE LANDSCAPE

7.1. Market Share Analysis

7.2. Market Positioning of Key Players

8. KEY MARKET PLAYERS

8.1. AstraZeneca (U.K.)

8.2. Bayer AG (Germany)

8.3. Gilead Sciences (U.S.)

8.4. GlaxoSmithKline (U.K.)

8.5. Johnson & Johnson (U.S.)

8.6. Merck & Co (U.S)

8.7. Novartis A.G. (Switzerland)

8.8. Pfizer (U.S.)

8.9. F. Hoffmann-La Roche AG (Switzerland)

8.10. Sanofi (France)

9. SCALAR 360 DEGREE MARKET PERSPECTIVE

10. APPENDIX

10.1. Definitions

10.2. Acronyms

10.3. Contact Us

10.4. Disclaimer

Contact us :

Scalar Market Research

Address : 8770 W Bryn Mawr Ave, Suite 1300 Chicago, IL 60631

[email protected]

+1-800-213-5170 (U.S. / Canada Toll-free)